- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02150005
Non-surgical Periodontal Treatment on Hemogram, Lipid and Glycemic Profiles in Patients With Coronariopathies
Effects of Non-surgical Periodontal Treatment on Hemogram, Lipid and Glycemic Profiles of Patients With an Indication for Surgical Coronary Revascularization
Objective: The aim of this study was to examine the effects of non-surgical periodontal treatment on the hemogram, glycemic and lipid profiles in cardiopathic patients with an indication for surgical revascularization.
Materials and Methods: Twenty-two patients with chronic periodontitis, over 35 years of age (mean age 59.45 years) randomly assigned into 2 groups were evaluated. Test group (n=11), received periodontal treatment before the surgical procedure, and control group (n=11), did not received periodontal treatment prior to surgery.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Undergoing cardiovascular treatment;
- Eight viable teeth in the oral cavity;
- Four periodontal sites with periodontal probing depths ≥5mm in different teeth.
Exclusion Criteria:
-
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Styring
|
|
|
Eksperimentel: Periodontal treatment
The test group received oral hygiene instructions, supragingival and subgingival scaling and root planning using curettes and an ultrasonic appliance.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Reduction in probing depth in sites with PPD>3mm
Tidsramme: Baseline and 90 days after the initial exam
|
Reduction of 11.4% in probing depth in sites with Periodontal Probing Depth>3mm
|
Baseline and 90 days after the initial exam
|
|
Reduction in probing depth in sites with PPD>5mm
Tidsramme: Baseline and 90 days after the initial exam
|
Reduction of 6.3% in probing depth in sites with Periodontal Probing Depth>5mm
|
Baseline and 90 days after the initial exam
|
|
Reduction in probing depth in sites with CAL>3mm
Tidsramme: Baseline and 90 days after the initial exam
|
Reduction of 4.6% in probing depth in sites with Clinical Attachment Level >3mm.
|
Baseline and 90 days after the initial exam
|
|
Reduction in probing depth in sites with CAL >5mm
Tidsramme: Baseline and 90 days after the initial exam
|
Reduction of 3.6% in probing depth in sites with Clinical Attachment Level >5mm.
|
Baseline and 90 days after the initial exam
|
|
Leukocyte count
Tidsramme: Baseline and 90 days after the initial exam
|
Non-significant reduction of leukocyte count in the test group.
Mean difference of 74.6 m/mcL.
|
Baseline and 90 days after the initial exam
|
|
Glucose
Tidsramme: Baseline and 90 days after the initial exam
|
Glucose showed a non-significant increase in the test group.
Mean difference of 24.2 mg/dL.
|
Baseline and 90 days after the initial exam
|
|
Hemocyte
Tidsramme: Baseline and 90 days after initial exam
|
Hemocyte presented a non-significant reduction in the test group.
Mean difference 0.39 m/mcL
|
Baseline and 90 days after initial exam
|
|
Hemoglobin
Tidsramme: Baseline and 90 days after initial exam
|
Non-significant reduction in test group.
Mean difference of 0.2 g/dL
|
Baseline and 90 days after initial exam
|
|
Total Cholesterol
Tidsramme: Baseline and 90 days after initial exam
|
Significant reduction in the test group.
Mean reduction of 27.4 mg/dL.
|
Baseline and 90 days after initial exam
|
|
High density lipid
Tidsramme: Baseline and 90 days after initial exam
|
Significant reduction in test group.
Mean difference of 8.2 mg/dL.
|
Baseline and 90 days after initial exam
|
|
Low density lipid
Tidsramme: Baseline and 90 days after initial exam
|
Non-significant reduction in test group.
Mean difference of 8.9 mg/dL.
|
Baseline and 90 days after initial exam
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- UVA71/06
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .